1 Overdose Sends North Carolina Woman To Hospital

Key Points:

• The use of GLP-1 drugs for weight loss has surged in the U.S., with about 11% of adults now reporting usage, often obtained through telehealth companies offering convenience but sometimes lacking proper medical supervision.
• An investigation revealed cases like Leslie Gammon's, who suffered a severe overdose and hospitalization after receiving compounded GLP-1 drugs via telehealth, highlighting risks from inadequate dosing guidance and limited follow-up care.
• From 2019 to 2025, calls related to overdoses or side effects of injectable GLP-1 drugs increased nearly 1,500%, raising concerns about patient safety, especially with compounded drugs that are not FDA-approved.
• Medical experts urge patients to seek telehealth providers who offer thorough communication and clinical oversight, and to be cautious about compounded GLP-1 drugs, which may have inconsistent dosing and safety profiles compared to FDA-approved brand-name medications.
• Industry groups and drug manufacturers warn against the use of mass-produced compounded GLP-1 drugs, calling for stronger regulatory oversight to ensure patient safety while maintaining access to legitimate compounded medications.